Excerpt Of Interview With Stephen Weiss On Auction Rate Securities Class Actions

Seeger Weiss’ founding partner Stephen Weiss was interviewed by a Bloomberg news staff writer to asses the current state of the Auction-Rate security class actions, pending in various courts. An excerpt of the article follows: “…We do not bring cases unless we think there is a very good basis,” said Jerome Congress, a partner with […]

March 17, 2008

Seeger Weiss’ founding partner Stephen Weiss was interviewed by a Bloomberg news staff writer to asses the current state of the Auction-Rate security class actions, pending in various courts. An excerpt of the article follows:

“…We do not bring cases unless we think there is a very good basis,” said Jerome Congress, a partner with Milberg LLP, a New York firm that filed a class action against Citigroup. Milberg was Lerach’s firm when he filed the Enron suit.

Lawyers who have decided to take cases include Stephen A. Weiss of New York-based Seeger Weiss, who estimated damages are “in the many billions of dollars.” Weiss represents clients in 12 of the class actions.

Lower Return

Weiss said the investors received a lower return on their investment than they would have from fixed-rate bonds for the easier ability to sell them. Given the auctions’ failures, the bonds should have paid a higher rate, he said.

Faced with the high penalty-rate interest, some issuers are buying back auction-rate securities. Municipal borrowers have refinanced, converted or indicated they will redeem at least $68 billion of auction bonds by July 7, according to data compiled by Bloomberg.

Some investors such as Bristol-Myers Squib Co. have written down auction-rate investments as required by U.S. accounting rules that could also enable them to reset the value higher if market conditions improve. Companies such as Google Inc. have written down more than $1.8 billion since the market collapse.

The Citigroup cases include LHB Insurance v. Citigroup, 08- cv-3095, and Swanson v. Citigroup, 08-cv-3139, U.S. District Court, Southern District of New York (Manhattan)…

Read the whole article

Source: Bloomberg.com

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More